Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death. 2011

Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
Division of Cardiac Surgery, The Keenan Research Centre in the Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, Canada. singhkk@smh.ca

P53 protein levels are elevated by trastuzumab and the biologically similar rat ERBB2/HER2/NEU antibody; and that this coincides with enhanced apoptosis, increased cleaved caspase-3 levels and diminished cardiac function. We also demonstrate that MDM2 may be a regulatory target of anti-ERBB2 thereby implicating the MDM2/p53 axis as a potential molecular component for the undesirable cardiac outcomes noted with trastuzumab. Finally, we show that these MDM2/p53-mediated events are independent of both the ERK1/2 and Akt systems. In conclusion, our findings suggest that the adverse cardiac events observed with trastuzumab may stem from its negative regulation of MDM2 events which impairs p53 degradation resultantly promoting apoptosis leading to cardiac dysfunction. These observations may have important therapeutic implications since they suggest that anticancer agents that inhibit MDM2 and its downstream actions may curb tumor progression at the expense of increasing cardiac stress.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000068878 Trastuzumab A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed. Trastuzumab beta,Trastuzumab-qyyp,Trazimera,Herceptin,Trastuzumab qyyp,beta, Trastuzumab
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
September 2004, British journal of cancer,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
January 2001, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
January 2001, Anticancer research,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
June 1999, Bulletin du cancer,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
March 2005, Dermatology online journal,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
August 2005, Clinical reviews in allergy & immunology,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
January 2015, Human vaccines & immunotherapeutics,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
April 2018, Investigational new drugs,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
May 2002, Transplant immunology,
Krishna K Singh, and Praphulla C Shukla, and Adrian Quan, and Fina Lovren, and Yi Pan, and Jesse I Wolfstadt, and Milan Gupta, and Mohammed Al-Omran, and Howard Leong-Poi, and Hwee Teoh, and Subodh Verma
September 2017, IUBMB life,
Copied contents to your clipboard!